Center of Excellence Recognizes High Degree of Experience with BPH Technology
Dedham, MA, May 25, 2021 — Greater Boston Urology today announced that Dr. Stephen Craig Gillard, who practices out of GBU's Plymouth Care Center, has been designated as the first Massachusetts Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Dr. Gillard is the first Center of Excellence in Massachusetts.
BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms, such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2
GreenLight Therapy can help provide immediate relief from these enlarged prostate symptoms. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1
The Center of Excellence designation recognizes Dr Gillard's high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from benign prostatic hyperplasia (BPH).1
"Being designated as a GreenLight Center of Excellence is a meaningful recognition for GBU as we strive to provide the best possible treatment of urological conditions for patients throughout Massachusetts," said Dr. Gillard. "For years, the primary options for treating BPH were through behavior modifications, medications, or invasive surgery. However, medications may not work for everyone and may have undesirable side effects, such as dizziness, sexual dysfunction, and lower sex drive.3 With GreenLight Therapy, we’re able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants."
GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1
GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.4
About Greater Boston Urology
Founded in 2010, Greater Boston Urology is an integrated urology practice. This medical model allows the practice to pool resources, which leads to more—and better—options for patients, such as 3D MRI/ultrasound fusion biopsy, high intensity focused ultrasound (HIFU), molecular marker studies, and pelvic floor physical therapy, to name just a few. GBU has assembled a team of excellent physicians who serve multiple locations in Greater Boston, the South Shore, and the Cape & Islands. In addition, GBU has a dedicated urogynecologist heading up its Women’s Health Centers in Dedham and Hyannis, Mass.
For more information, visit GreaterBostonUrology.com or TreatMyBPH.com.
- Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.
- What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic hyperplasia-(bph).
- Roger K, Gilling P. Fast Facts: Benign Prostatic Hyperplasia, 7th edition. Health Press. 2011.
- Data on file with Boston Scientific.
* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the use of referenced technologies but may not be appropriate for every patient or case. Decisions surrounding patient care depend on the physician’s professional judgment in consideration of all available information for the individual case. Boston Scientific (BSC) does not promote or encourage the use of its devices outside their approved labeling. Case studies are not necessarily representative of clinical outcomes in all cases as individual results may vary.
TreatMyBPH.com is a website sponsored by Boston Scientific.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
©2020 Boston Scientific Corporation or its affiliates. All rights reserved. URO-826605-AA JUL 2020